Phys Vivas · infectious
Sexually Transmitted Infections — Viva Defence
DCE viva defence for Sexually Transmitted Infections.
On this page & tools
Target exams
Sexually Transmitted Infections Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Sexually Transmitted Infections. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
Short case
Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]
References
- [1]Relyea Ashley HM, Stuart SK, Eaton EF Attention-deficit/hyperactivity disorder, autism spectrum disorder, and HIV: implications for risk, outcomes, and care for neurodivergent people Top Antivir Med, 2026.PMID 42467809
- [2]Iriarte E, Erlandson KM Interventions and opportunities to enhance aging among people with HIV: a focus on frailty, sarcopenia, and intrinsic capacity Top Antivir Med, 2026.PMID 42467808
- [3]Scarsi KK, Marzolini C, Marra F, Tseng AL Selected highlights from the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs Top Antivir Med, 2026.PMID 42467807
- [4]David M, Balint N, Fryszer L, Germerott T, et al. Recommendations for the Care and Support of Women Affected by Sexual Violence. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/097, December 2025, Version 1.0) Geburtshilfe Frauenheilkd, 2026.PMID 42459841
- [5]Burchell AN, Grennan T, Fahim C, Gaid D, et al. Application of the Cascade of Care Framework to Guide Evidence-Informed Implementation of Anal Cancer Screening Guidelines Cancer Control, 2026.PMID 42432992
- [6]Zimet GD, Kasting ML, Thompson EL, Head KJ Shared clinical decision-making for vaccination: A view through the lens of mid-adult HPV vaccination Hum Vaccin Immunother, 2026.PMID 42417053
- [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922